Dr. Juan Camilo Arjona Ferreira - 18 Jul 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jul 2022
Net transactions value
-$20,669
Form type
4
Filing time
20 Jul 2022, 16:35:08 UTC
Previous filing
08 Jul 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $20,669 -1,606 -0.63% $12.87 254,386 18 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.